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Abstract Cellular adaptation to various types of
stress requires a complex network of steps that
altogether lead to reconstitution of redox balance,
degradation of damaged macromolecules and restora-
tion of cellular metabolism. Advances in our under-
standing of the interplay between cellular signalling
and signal translation paint a complex picture of multi-
layered paths of regulation. In this review we explore
the link between cellular adaptation to metabolic and
oxidative stresses by activation of autophagy, a crucial
cellular catabolic pathway. Metabolic stress can lead
to changes in the redox state of nicotinamide adenine
dinucleotide (NAD), a co-factor in a variety of
enzymatic reactions and thus trigger autophagy that
acts to sequester intracellular components for recy-
cling to support cellular growth. Likewise, autophagy
is activated by oxidative stress to selectively recycle
damaged macromolecules and organelles and thus
maintain cellular viability. Multiple proteins that help
regulate or execute autophagy are targets of post-
translational modifications (PTMs) that have an effect
on their localization, binding affinity or enzymatic
activity. These PTMs include acetylation, a reversible
enzymatic modification of a protein’s lysine residues,
and oxidation, a set of reversible and irreversible
modifications by free radicals. Here we highlight the
latest findings and outstanding questions on the
interplay of autophagy with metabolic stress, present-
ing as changes in NAD levels, and oxidative stress,
with a focus on autophagy proteins that are regulated
by both, oxidation and acetylation. We further explore
the relevance of this multi-layered signalling to
healthy human ageing and their potential role in
human disease.
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Introduction
NAD depletion, oxidative stress and loss of macroau-
tophagy (from herein referred to as autophagy)
efficiency have all been linked to healthy, pathological
and premature ageing (Kubben and Misteli 2017;
Lo´pez-Otı´n et al. 2013, 2016). Individually, these
alterations may underlie seven of the nine outlined
hallmarks of ageing including genomic instability
(all), telomere attrition (oxidative stress), epigenetic
alterations (NAD), loss of proteostasis (autophagy),
de-regulated nutrient sensing (NAD), cellular senes-
cence (all) and mitochondrial dysfunction (all)
(Lo´pez-Otı´n et al. 2013, 2016). Moreover, it is
becoming increasingly clear that a significant degree
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of crossover and interdependence between the three
phenomena occur in ageing cells and tissues. Specif-
ically, increased reactive oxygen species (ROS) and
depletion of NAD can impact autophagy by influenc-
ing post-translational modifications (PTMs) of autop-
hagy proteins (Filomeni et al. 2015; Sedlackova et al.
2020; Zhang et al. 2016a). Furthermore, autophagy
impairment may lead to the failure to reconstitute
cellular metabolism and detoxify oxidised substrates
(Li et al. 2015; Morishita and Mizushima 2019).
Nicotinamide adenine dinucleotide (NAD)
NAD is an essential metabolite that participates in
cellular energy generation and signalling. When
plentiful, the redox balance and availability of NAD
aid cellular adaptation to metabolic stress and help
maintain genomic stability, mitochondrial function,
detoxification of ROS and cell survival (Fang et al.
2017). Due to its ability to accept or donate electrons,
NAD in its reduced (NADH) or oxidised (NAD?)
form assists energy metabolism in the cytosol and
within mitochondria (Canto et al. 2015). In addition,
NAD? is cleaved into ADP-ribose (ADPR) and
nicotinamide (NAM) by three classes of enzymes:
sirtuins (SIRTs), poly(ADPR) polymerases (PARPs)
and cyclic ADPR synthases (CD38 and CD157)
(Fig. 1), which require ADPR for their enzymatic
activity (Canto et al. 2015; Fang et al. 2017).
Crucially, although SIRT activity depends on NAD?
availability and cannot contribute to uncontrolled
NAD? cleavage, PARPs and CD38 are known for
their indiscriminate NAD? consumption and their role
in age- and disease-related NAD depletion (Canto
et al. 2015). Homeostasis of intracellular NAD pools is
maintained by either local synthesis from NAD?
precursors (nicotinamide (NAM), nicotinamide ribo-
side (NR) or nicotinamide mononucleotide (NMN)) or
centralised de novo synthesis from nicotinic acid or
L-tryptophan (Canto et al. 2015). Therefore, it is the
balance between NAD? cleavage and synthesis that
dictates the total intracellular NAD pool, and by
extension, cellular metabolism and protein acetylation
status (Strømland et al. 2019).
Reactive oxygen species (ROS)
ROS are highly reactive molecules of oxygen, which
harbour one unpaired electron (superoxide anion
(O2
•-), hydroxyl radical (OH•)) or an additional
Fig. 1 Molecular outcomes of NAD? cleavage. The three
major groups of NAD?-consuming enzymes include sirtuins
(SIRT), poly(ADP-ribose) polymerases (PARPs) and cyclic
ADP-ribose synthases (cADPRs, CD38, CD157). a SIRT1-3 are
NAD ? -dependent deacetylases that bind an acetylated (Ac)
protein substrates and transfer the Ac moiety onto ADP-ribose
(ADPR) to give rise to O-acetyl-ADP-ribose, a deacetylated
protein substrate and a by-product of the reaction, nicotinamide
(NAM). b PARPs are indiscriminate NAD? consumers that use
NAD? as a co-substrate to generate poly(ADP)-ribose (PAR)
chains on protein substrates, and generate NAM as a by-product.
c cADPRs consume NAD? to generate cyclic ADP-ribose
(cADPR), a second messenger, and a by-product, NAM
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electron pair (H2O2) on its valence orbital (Halliwell
and Gutteridge 2015). The increased electron content
in oxygen molecules makes them more reactive and
more likely to participate in one-electron oxidative
transfer reactions that lead to macromolecule modifi-
cation and/or damage (Halliwell and Gutteridge
2015). ROS can also interact with nitric oxide to
generate reactive nitrogen species (RNS), including
peroxynitrite (ONOO-) (Bartesaghi and Radi 2018).
Electrons from ROS/RNS interact with amino acid
residues incorporated in proteins and thus translate the
cellular redox state into protein activating or inhibiting
signals by the modulation of protein enzymatic
activity, binding affinity or structural conformation.
Particularly sensitive to ROS-mediated redox regula-
tion are cysteine (Cys) residues (Bischoff and Schlu¨ter
2012). Cys is one of the least represented, and yet often
highly conserved amino acids that participates in
protein structural integrity by formation of covalent
disulphide-bridges between two cysteine residues, or
protein enzymatic activity, i.e. by thioester bond
formation or co-factor stabilisation (Bak et al. 2019;
Marino and Gladyshev 2010).
Autophagy
Autophagy is a cytosolic pathway of dynamic mem-
brane rearrangement and cargo sequestration that is
assisted and executed by a set of highly conserved
autophagy (ATG) proteins (Dikic and Elazar 2018).
Autophagy is a catabolic process responsible for cargo
recognition, its engulfment in a double membraned
vesicle called autophagosome and delivery to the
lysosomal lumen for degradation. The subsequent
release of amino acids, lipids and nucleosides recon-
stitutes cellular homeostasis and sustains viability in
times of stress (Morishita and Mizushima 2019). The
molecular execution of autophagy initiation is medi-
ated by ATG protein association into functional
complexes known as the Unc-51-like kinase 1
(ULK1) complex, the class III phosphatidylinositol 3
kinase (PI(3)K) complex, the ATG9-membrane com-
plex, an ATG2–WIPI (WD-repeat protein interacting
with phosphoinositides) complex and two conjugation
systems consisting of the ATG3-ATG8/LC3 and the
ATG5-ATG12:ATG16L complex (Table 1) (Suzuki
et al. 2017). The combined action of these complexes
is responsible for ER localization of all autophagy
components and for the formation and maturation of
the autophagic membrane. In addition, a group of
autophagy receptors, e.g. sequestosome 1 (SQSTM1/
p62), is then responsible for spatially linking the
ubiquitylated cargo, including long-lived or aggre-
gated proteins, pathogens and organelles, to the
growing autophagosome (Dikic and Elazar 2018;
Johansen and Lamark 2019).
The canonical pathway of starvation-induced
autophagy was long thought to rely on phosphoryla-
tion cascades that are triggered by the loss of nutrient
signalling and converge on a small number of
regulating kinase complexes (Beurel et al. 2015;
Rabanal-Ruiz et al. 2017; Tamargo-Go´mez and
Marin˜o 2018). These regulators then either lose
function and thus release downstream autophagy
components from an inhibitory state, or become
activated and promote autophagy initiation. In addi-
tion, multiple layers of regulation involved in
autophagy initiation, cargo sequestration and degra-
dation, incorporate various stress signals and often
improve the efficiency of autophagic flux via PTMs of
autophagy proteins or their upstream regulators
(Filomeni et al. 2015; Montagna et al. 2016; Sedlack-
ova et al. 2020; Zhang et al. 2016a).
In this review, we explore the current knowledge of
how two types of PTMs, lysine (Lys) acetylation and
cysteine (Cys) oxidation, regulate the abundance and
activity of ATG proteins, and highlight which Lys
modifications are subject to NAD? availability. We
then summarize the main concepts of autophagy
regulation by oxidative stress and discuss the impli-
cations and consequences of age-related changes to
NAD? availability and an increase in oxidative stress
on the efficiency of autophagy. We further explore
whether autophagy directly influences the homeostasis
of cellular NAD levels and outline how aberrations in
either of the three phenomena could lead to dysfunc-
tion observed in physiological and pathological
ageing.
Targets of acetylation in autophagy
Lysine acetylation is a major reversible PTM in
eukaryotes that arises by donation of the acetyl moiety
from acetyl coenzyme A (Ac-CoA) via its re-direction
from mitochondrial energy generation (Drazic et al.
2016). Protein acetylation status is balanced by the
activity of multiple lysine acetyl transferases (KATs,
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historically known as histone acetyl transferases
HATs) and lysine deacetylases (KDAC, or HDACs)
(Narita et al. 2019). KATs catalyse acetyl moiety
transfer from Ac–CoA to a lysine residue of the target
protein, while KDACs cleave and release the acetyl
moiety (KDAC, classes I, II and IV) or catalyse
transfer of the acetyl moiety onto ADPR, a product of
NAD? cleavage (class III KDACs, sirtuins (SIRTs)
(Fig. 1). Acetylation status of autophagy proteins is
largely controlled by p300 (KAT3B) and 60 kDa Tat-
interactive protein (TIP60/KAT5) KATs and SIRT1-3
and HDAC2/6 KDACs (summarized in Table 1). In
the next section, we explore how protein acetylation
status, generally high in conditions of nutrient abun-
dance and low under nutrient starvation, regulates the
activity and localisation of TFs, proteins and receptors
involved in autophagy.
Regulation of transcription factors involved
in autophagy gene transcription
The loss of lysine acetylation triggers stimulation of
several TFs involved in the transcription of ATG genes
(Fig. 2a) (Fu¨llgrabe et al. 2016). The strongest link
between TF deacetylation and autophagy stimulation
comes from studies of transcription factor EB (TFEB),
a member of the microphthalmia family of bHLH-LZ
transcription factors (Mit/TFE), a group of TFs that
stimulate lysosomal biogenesis and expression of
autophagy proteins (Yang et al. 2018). Specifically,
TFEB is responsible for transcription of multiple
autophagy genes (ATG4, ATG9B, MAP1LC3B
(LC3B), UVRAG (UV radiation resistance associated
gene), WIPI (WD repeat domain phosphoinositide-
interacting protein 1), and SQSTM1 (p62)) (Fu¨llgrabe
Table 1 Acetylation-sensitive proteins in autophagy
Protein Function in
autophagy
Acetylation sensitive Lys
residues
Acetylase Deacetylase Outcome of deacetylation
TFEB Transcription factor (Lys91), (Lys103), Lys116,
Lys274, Lys279 and (Lys430)
ACAT1?
GCN5
SIRT1
HDAC2/6
Increased lysosomal biogenesis,
transcription of ATG proteins
FoxO1 Transcription factor Lys242, Lys245,
Lys262 (mouse residues)
CBP,p300 SIRT1 Increased DNA binding
FoxO3a Transcription factor Unknown Unknown SIRT1-3 Cytoplasm to nucleus translocation
ULK1 ULK1 complex
member
Lys162 and Lys606 TIP60 Unknown Loss of kinase activity stimulation
VPS34 Class III PI3K kinase
complex member
Lys29, Lys771, (Lys781) p300 Unknown Increased complex formation (Lys29),
increased PI binding (Lys771)
Beclin
1
Class III PI3K kinase
complex member
Lys430 and Lys437 p300 SIRT1 Autophagosome maturation
ATG3 Autophagosome
elongation
Lys19, Lys48, Lys183 (yeast
residues)
TIP60 HDAC1/2 Decreased membrane-binding
ATG7 Autophagosome
elongation
Unknown p300 SIRT1 Increased LC3-PE formation
ATG5 LC3–PE
deconjugation
Unknown p300 SIRT1
SIRT2
SIRT3
Increased LC3-PE formation
ATG12 LC3–PE
deconjugation
Unknown p300 Unknown Increased LC3-PE formation
LC3 Multiple Lys49 and Lys51 p300 SIRT1 Increased levels of LC3-PE formation
Ub Selectivity Lys6 and Lys48 Unknown Unknown Poly-Ub chain formation
p300 Inhibits autophagy Multiple p300 SIRT2 Loss of inhibitory ATG5/ATG7/
ATG12/LC3 acetylation
p62 Selective cargo
recognition
Lys420 and Lys435 TIP60 HDAC6 Increased Ub binding
() lysine residues sensitive to acetylation, but their involvement in autophagy regulation remains unknown
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et al. 2016; Settembre et al. 2011). Acetylation of a
conserved lysine residue Lys116 was independently
identified in three studies as a modifier of TFEB
activity in microglia (Bao et al. 2016) and in cancer
cells (Wang et al. 2019b; Zhang et al. 2018). In
microglia, Lys116 was directly deacetylated by SIRT1
which promoted degradation of fibrillar amyloid b
(Bao et al. 2016). In cultured cells, treatment with a
KDAC inhibitor, suberoylanilide hydroxamic acid
(SAHA), increased the transcriptional activity of
TFEB and influenced acetylation of four lysine
residues (Lys91, Lys103, Lys116 and Lys430) (Zhang
et al. 2018). In addition, authors of this study identified
acetyl-coenzyme A acetyltransferase 1 (ACAT1) and
HDAC2 as modulators of the overall TFEB acetyla-
tion status. Furthermore, a study in a model of chronic
kidney disease identified HDAC6 as another KDAC
involved in the regulation of TFEB activity (Brijmo-
han et al. 2018). Importantly, authors of neither of the
studies demonstrated a direct interaction between
TFEB and HDAC2 or HDAC6, respectively (Brijmo-
han et al. 2018; Zhang et al. 2018). Overexpression of
another KAT, the general control non-repressed
protein 5 (GCN5/KAT2A), but not TIP60, p300 or
CREB-binding protein (CBP), led to increased TFEB
acetylation of Lys116, Lys274 and Lys279 residues
Fig. 2 Autophagy targets of acetylation and oxidation. Nutrient
and oxidative stresses affect proteins that participate in
autophagy by lysine (K) acetylation or cysteine (C) oxidation.
a Localization of transcriptional factor EB (TFEB), a master
regulator of autophagy and lysosomal gene expression, is
regulated by oxidative stress. Indirectly, oxidative modification
of mucolipin 1 (MCOLN1) leads to TFEB dephosphorylation by
Ca2?-sensitive phosphatase, calcineurin and its translocation to
the nucleus. Directly, oxidation of TFEBs redox-sensitive
residue, C212, promotes rapid nuclear localization. In addition,
inhibitory lysine acetylation of K274 and K279 that is regulated
by the general control non-repressed protein 5 (GCN5) prevents
TFEB dimerization. The molecular and functional outcomes of
K116 are not known, but are opposed by nutrient sensitive,
NAD ? -dependent lysine deacetylase (KDAC), SIRT1.
b Acetylation-sensitive lysine residues were detected within
members of the ULK1 complex, the class III PI(3)K complex
and both ubiquitin-like conjugation systems. Unc-51-like kinase
1 (ULK1, ULK1 complex) contains two lysine residues, K162
and K606 (* in mouse) that are acetylated by TIP60 in response to
serum starvation. Vacuolar protein sorting 34 (VPS34, class III
PI(3)K complex) contains two acetylation sensitive lysine
residues (K29 and K771) that are subject to inhibitory acetylation
in fed conditions. Inhibitory acetylation of residues K430 and
K437 in Beclin 1 (class III PI(3)K complex) is opposed by
nutrient-sensitive SIRT1 KDAC. Within the ubiquitin-like
conjugation systems, LC3 (K49, K51), ATG5 (unknown),
ATG7 (unknown) and ATG12 (unknown) are subject to
inhibitory acetylation by p300 (not shown) in fed conditions.
Acetylation of LC3, ATG5 and ATG7 residues is opposed by
SIRT1 deacetylase. ATG3 is subject to activating acetylation by
TIP60 in starved conditions. Acetylation of lysine residues K19,
K48 and K183 (** in yeast) is necessary for ATG3 enzymatic
activity and LC3 binding affinity. ATG3 and ATG7 are also
subject to inactivation by oxidative stress due to oxidation of
their catalytic thiols, C264 and C572, respectively. c Selective
autophagy receptor p62 is a target of both, acetylation and
oxidation. TIP60-dependent activating acetylation of K420 and
K435 residues within the ubiquitin-associated (UBA) domain
prevent UBA dimerization and enhance ubiquitin (Ub) binding
affinity. Oxidation of C105 and C113 promotes p62 oligomeriza-
tion and stimulates autophagy by intermolecular disulphide
bond formation
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(Wang et al. 2019b). Authors further demonstrated
that TFEB acetylation at Lys274 and Lys279 mecha-
nistically disrupts TFEB dimerization and its ability to
bind DNA, and thus negatively regulates expression of
lysosomal and autophagy genes (Fig. 2A) (Wang et al.
2019b). Crucially, Lys116 of TFEB is not conserved in
Drosophila melanogaster and Caenorhabditis elegans
or in other members of the Mit-TFE family (Wang
et al. 2019b), thus SIRT1 and HDAC regulation of
TFEB activity is likely to be unique to vertebrates.
Additionally, two members of the forkhead box
class O (FoxO) TF family, FoxO1 and FoxO3a,
recognized for their role in autophagy/mitophagy
(ATG4, ATG5, ATG12, ATG14, BECN1 (beclin 1),
BNIP3 (BCL2 interacting protein 3), LC3B, ULK1,
VPS34 (vacuolar protein sorting 34) GABARAPL1
(gamma-aminobutyric acid receptor-associated pro-
tein-like1), and PARK6/PINK1 (PTEN-induced
kinase 1)) gene transcription, are regulated by acety-
lation PTMs (Fang et al. 2019; Fu¨llgrabe et al. 2016;
Requejo-Aguilar et al. 2015). It was first demonstrated
that FoxO1 acetylation on Lys242, Lys245 and Lys262
residues (in mice) by CBP is opposed by SIRT1 in
response to serum (Daitoku et al. 2004) and glucose
starvation (Hariharan et al. 2010). Mechanistically,
acetylation of the three Lys residues within FoxO1
interferes with its DNA binding and inhibits its
transcriptional activity (Matsuzaki et al. 2005). Fur-
thermore, FoxO1 acetylation permits access for
upstream kinases to phosphorylate its Ser253 residue
that is otherwise shielded by FoxO1-DNA complex
formation (Matsuzaki et al. 2005). FoxO1 phosphory-
lation sites have since became known to act as docking
or shielding sites for 14–3-3 protein binding, and the
heterodimer exit into and retention within the cyto-
plasm (Brunet et al. 1999; Saline et al. 2019).
Similarly to FoxO1, the transcriptional activity of
FoxO3 is modulated by SIRT1-3 deacetylases, though
the Lys residues susceptible to acetylation remain
unknown. First, caloric restriction and oxidative stress
increase SIRT2 expression, decrease FoxO3 acetyla-
tion and improve gene transcription (Wang et al.
2007). In mitochondria, SIRT3 mediated deacetyla-
tion of the mitochondrial FoxO3 pool and led to
cellular detoxification of oxidative stress by increased
expression of the mitochondrial superoxide dismutase
(Jacobs et al. 2008). However, some controversy
exists in the perceived outcome of FoxO acetylation.
A few articles published in early 2000s reported
entirely opposite findings, demonstrating that FoxO
acetylation improves transcription of its target genes
(Motta et al. 2004; Yang et al. 2005). The pitfall of the
majority of FoxO studies centres on the lack of
distinction between CBP-mediated acetylation of
FoxO, which may increase its DNA binding, and
acetylation of histones, which would relax the chro-
matin condensation and promote gene transcription
(discussed in detail in (Daitoku et al. 2011)).
Overall, transcriptional activity of TFEB, amember
of the Mit/TFE family, and two FoxO isoforms,
FoxO1 and FoxO3, is regulated by acetylation. Three
classes of KDACs, SIRT1, HDAC2/6 and GCN5, are
thought to deacetylate multiple and variable Lys
residues in TFEB, of which the SIRT1 target, Lys116,
is unique to vertebrates, and Lys274 and Lys279
deacetylation regulates TFEB-DNA complex forma-
tion (Wang et al. 2019b). In the FoxO family, FoxO1 is
the better studied isoform, with known target Lys
residues in the mouse (Table 1), though both FoxO1
and FoxO3a are likely activated by SIRT-mediated
deacetylation. Thus, transcriptional regulation of
autophagy/mitophagy genes by TFEB and FoxO1/3a
is, at least in part, responsive to intracellular NAD?
levels that influence SIRT activity.
Regulation of autophagy protein complexes
Several autophagy proteins involved in autophago-
some formation, growth and maturation may be
modified by acetylation (Table 1). Studies from the
last decade, summarized below, identify lysine
residues sensitive to acetylation in members of the
ULK1 kinase complex, the class III PI(3)K kinase
complex and the two conjugation systems, ATG12
(ATG7, ATG10, ATG5) and LC3 (ATG4, ATG7,
ATG3), as well as ATG12 and LC3 themselves
(Fig. 2B).
In the ULK1 complex, ULK1 itself is a target of
acetylation by TIP60 (Lin et al. 2012). In serum
starved cells, ULK1 was shown to be a target of
GSK3-dependent and TIP60-mediated acetylation of
two crucial residues, Lys162 and Lys606 (in mouse;
likely Lys162 and Lys607 in human), that together
stimulate its kinase activity and promote autophagy
initiation (Lin et al. 2012). Furthermore, oxidative
stress that induces ER stress, was also shown to
stimulate ULK1 acetylation by a GSK3-TIP60-de-
pendent mechanism (Nie et al. 2016). These studies
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together support the idea that ULK1 kinase activity
can be modulated by oxidative and metabolic stress
via an upstream signalling cascade that results in
TIP60 activation and ULK1 acetylation.
Within the Class III PI(3)K complex, VPS34 kinase
acetylation by p300 occurs on residues Lys29, Lys771
and Lys781 and inhibits its lipid kinase activity and
PI(3)P production (Su et al. 2017). It was further
determined that acetylation of Lys29 residue prevents
VPS34 association with Beclin 1 that is required for
the formation of a complex involved in autophagy
progression. Another layer of VPS34 activity regula-
tion occurs upon acetylation of the Lys771 residue
located within its catalytic site. In a manner similar to
the level of regulation at the Lys29 residue, acetylation
of Lys771 disrupts binding between VPS34 and its
substrate, PI (Su et al. 2017). However, the KDAC
responsible for Lys29 and Lys771 deacetylation
remains unknown. In addition to VPS34, Beclin 1 of
the Class III PI(3)K complex is also a target of
inhibitory acetylation on Lys430 and Lys437 residues
by p300 (Sun et al. 2015). Beclin 1 acetylation was
demonstrated to promote its binding to Rubicon, and
thus shown to result in the loss of autophagosome
maturation (Ohashi et al. 2019; Sun et al. 2015).
Furthermore, in vitro acetylation analysis revealed that
SIRT1 is preferentially responsible for Beclin 1
deacetylation (Sun et al. 2015).
Next, SIRT1-mediated deacetylation of nuclear
LC3 at Lys49 and Lys51 residues initiates LC3
translocation to the cytoplasm via a diabetes and
obesity regulated (DOR/TP53INP2)-dependent inter-
action with deacetylated LC3 (Huang et al. 2015).
DOR then further assists in LC3 localization to
nascent autophagosomes thanks to its ATG7-binding
affinity (You et al. 2019b). Furthermore, DOR also
contains a ubiquitin-interacting motif and is thus likely
to promote LC3-ATG7 formation in the vicinity of
ubiquitylated cargo (Xu and Wan 2019; You et al.
2019b). Upon relocation to the cytoplasm, LC3 Lys49
and Lys51 acetylation, that is lost upon nutrient
starvation, was recently shown to completely abolish
p62 binding (Song et al. 2019). Due to the location and
conservation of the two critical lysine residues in the
hydrophobic binding grooves of LC3 (Huang et al.
2015; Song et al. 2019), it stands to reason that Lys49
and Lys51 acetylation could disrupt LC3 interaction
with multiple binding partners including, but not
limited to DOR and p62. Altogether, LC3
deacetylation in response to nutrient starvation not
only promotes its exit from the nucleus, but also
determines substrate binding specificity of protein
partners via their LC3-interacting regions (LIRs).
Cytoplasmic LC3 targeting to and docking on the
nascent autophagosomes requires covalent conjuga-
tion of LC3 to phosphatidylethanolamine (PE). In a
ubiquitin-like conjugation system, ATG7 (and E1-like
enzyme), ATG3 (an E2-like enzyme) and an ATG5-
ATG12:ATG16L complex (an E3-like enzyme) assist
LC3 conjugation to PE (Dikic and Elazar 2018).
Nutrient starvation in yeast was first reported to
decrease or not change acetylation levels of ATG
proteins, with the notable exception of ATG3, in
which Lys19, Lys48 and Lys183 acetylation increased
(Yi et al. 2012). Authors of this study had further
shown that while acetylation of Lys183 is crucial for
the enzymatic activity of ATG3, Lys19 and Lys48
acetylation was crucial for autophagy progression by
improving interaction between ATG3 and ATG8 (LC3
in mammals), and was regulated by the opposing
activities of the yeast histone acetyltransferase Esa1
(TIP60/KAT5 orthologue)) and a histone deacetylase
Rpd3 (HDAC1/2 orthologue) enzymes. Furthermore,
ATG3 acetylation on Lys19 and Lys48 was shown to
enhance its ER membrane localization and binding
in vitro (Li et al. 2017).
Other members of the ubiquitin-like conjugation
system, ATG7, ATG5 and ATG12, are targets of
p300-mediated acetylation (Lee and Finkel 2009) and
SIRT1-dependent deacetylation (Lee et al. 2008). In
direct contrast to ULK1 and ATG3, acetylation of
these ATG proteins generally inhibits their function.
However, the specific residues, their location and
effect of acetylation on the structure or function of
ATG proteins remains unknown. Structural studies of
the ATG12-ATG5:ATG16 complex (Otomo et al.
2013) and the nature of interaction between ATG12
and ATG3 (Metlagel et al. 2013) point towards several
key lysine residues that could be targets of acetylation
in ATG12. First, lysine residues 60, 69, 71 and 128
located on the surface of ATG12 (Metlagel et al. 2013)
could contribute to binding affinity between ATG12
(E3-like) and ATG3 (E2-like) that is required for the
spatiotemporal regulation of LC3 lipidation. Further-
more, ATG5 contains multiple lysine residues, of
which Lys53, Lys130, Lys171 are conserved (Matsushita
et al. 2007). Although Lys130 is the known catalytic
site for conjugation between ATG5 and ATG12
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(Mizushima et al. 1998), the function and acetylation-
sensitivity of Lys53 and Lys171 remain unknown.
Lastly, no published study followed-up reports of
ATG7 acetylation-sensitivity (Lee et al. 2008; Lee and
Finkel 2009). However, a high resolution mass
spectrometry study of global protein acetylation
identified Lys306 of the human ATG7 protein as a
residue that might be relevant for further study
(Choudhary et al. 2009). Thus, although ATG5,
ATG7 and ATG12 have been known substrates of
p300 and SIRT for almost a decade, the lysine residues
sensitive to acetylation, or indeed the nature of protein
inhibition by acetylation have not been elucidated.
Selective cargo recognition
Autophagy receptors modulate the selectivity and
specificity of cargo recognition in the autophagy
pathway. Although the current knowledge of about
PTMs that affect the structure, function and localisa-
tion of the canonical autophagy receptors is fairly
limited, phosphorylation and ubiquitylation sites were
identified in all canonical receptors (THANATOS,
https://thanatos.biocuckoo.org) (Deng et al. 2018).
The best characterization of acetylation-dependent
regulation of autophagy receptors concerns the p62
protein and its affinity for ubiquitin (Fig. 2c). Binding
between ubiquitin and p62 to spatially link cargo to the
forming autophagosome is, in fed condition, restricted
due to the low binding activity of the ubiquitin asso-
ciated (UBA) domain of p62 and further restricted by
UBA homodimerisation (Long et al. 2010). Briefly,
Lys420 monoubiquitylation (Lee et al. 2017; Peng et al.
2017), and Ser403 and Ser407 (in humans; Ser405 and
Ser409 in mice) phosphorylation (Matsumoto et al.
2015) strengthen the interaction and binding affinity
between p62 and ubiquitin. In addition, acetylation of
p62 Lys420 and Lys435 residues, regulated by TIP60
and opposed by HDAC6 upon serum and amino acid
starvation, interferes with UBA dimerization (Lys420
and Lys435) and enhances ubiquitin-binding affinity
(Lys435) (You et al. 2019a). Moreover, spatial prox-
imity between p62 and HDAC6 at sites of protein
aggregation promotes their interaction and regulation
of HDAC6 deacetylase activity and, by extension,
protein aggregate recycling by p62 (Yan et al. 2013).
Moreover, ubiquitin (Ub) itself is a target of lysine
acetylation (Ohtake et al. 2015). Formation of
stable polyubiquitin chains by covalent linkages of
single Ub moieties via homotypic Lys63 linkage (also
known as K63) promotes autophagy (Grumati and
Dikic 2018). Although the KAT(s) and KDAC(s) in-
volved and the physiological relevance of Ub acety-
lation remain unknown, acetylation of Lys6 and Lys48
residues was shown to interfere with poly-Ub chain
formation (Lys11-, Lys48- and Lys63-linked) in vitro
(Ohtake et al. 2015).
Demystification of the acetylation riddle
in autophagy regulation
Recent advances in our understanding of which KATs
and KDACs are involved in the regulation of
autophagy protein acetylation highlight a few inter-
esting phenomena. Overall, autophagy protein acety-
lation status is mainly regulated by p300, CREB
binding protein (CBP) and TIP60 KATs, and HDAC2/
6 and SIRT1 KDACs (Table 1). Upon a closer look,
targets of p300-mediated acetylation are generally
opposed by SIRT1-dependent deacetylation, while the
targets of TIP60 may be opposed by HDACs but
remain largely unknown. Following this train of
thought, targets of p300/SIRT are activated by the
loss of acetylation, whereas it is the addition of acetyl
group to TIP60 targets that triggers their activation
(summarized in Table 1, shown in Fig. 2).
Autophagy is stimulated by the depletion of key
nutrients including amino acids, growth factors and
glucose. Recognition of nutrient availability by mul-
tiple intracellular sensors converges on a handful of
regulators that integrate nutrient signals into several
key responses. These include mammalian target of
rapamycin complex 1 (mTORC1) (Rabanal-Ruiz et al.
2017), glycogen synthase kinase 3 (GSK3) (Manci-
nelli et al. 2017), and adenine monophosphate-
activated protein kinase (AMPK) (Tamargo-Go´mez
and Marin˜o 2018). Perhaps unsurprisingly, these three
kinases have also been directly linked to the regulation
of KATs and KDACs that influence the acetylation
status of autophagy proteins. mTORC1 was recently
shown to activate the acetyl-transferase activity of
p300 by serine phosphorylation that was lost upon
amino acid starvation (Wan et al. 2017). Activation of
GSK3b by the loss of growth factor signalling is
known to phosphorylate and thus activate TIP60 (Lin
et al. 2012). Finally, AMPK activation releases SIRT1
inhibition in a GAPDH-dependent manner in response
to glucose starvation (Chang et al. 2015). Thus, three
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potential axes regulate autophagy stimulation in
response to nutrient stress by (a) loss of FoxO,
VPS34, Beclin1, ATG7, ATG5 and ATG12 acetyla-
tion (amino acids/growth factors-mTORC1-p300),
(b) increased ULK1 and possible ATG3 and p62
acetylation (serum/ER stress-GSK3b-TIP60) (Lin
et al. 2012; Nie et al. 2016; Yi et al. 2012; You et al.
2019a), and (c) FoxO, Beclin1, ATG7, ATG5 and
ATG12 deacetylation (glucose–AMPK–GAPDH–
SIRT1) that could explain the conundrum of the
varied nature of autophagy protein acetylation status
upon nutrient starvation and its link to autophagy
stimulation.
Targets of cysteine oxidative PTMs in autophagy
Protein modification by ROS and RNS constitutes a
covalent modification of amino acid residues by the
reactive species directly, or as a secondary interaction
in an oxidative relay. Briefly, irreversible (carbonyla-
tion, nitration) oxidative modifications affect a variety
of amino acids including cysteine (Cys), threonine and
tyrosine (Ahmad et al. 2017; Cai and Yan 2013; Xie
et al. 2018). In contrast, reversible amino acid
oxidation involves modification of the thiol group (-
SH) of Cys protein residues that are first modified to
sulfenic acid (–SOH) (Cai and Yan 2013). Sulfenic
acid can then undergo nitrosylation (-SNO) by react-
ing with RNS, or disulphide bond formation (R–S–S–
R) by intra-/inter-molecular bond formation between
two cysteine residues. A specialised form of disul-
phide bond formation, glutathionylation (R–S–S–G)
arises as a mixed disulphide bond formation between a
target protein Cys residue and the non-enzymatic
antioxidant, glutathione (GSH) (Cai and Yan 2013).
Further oxidation of –SOH results in an irreversible
Cys oxidation by the formation of sulfinic (–SO2H)
and sulfonic (–SO3H) acids (Ahmad et al. 2017; Cai
and Yan 2013; Murray and Van Eyk 2012). Autop-
hagy regulation by ROS is linked to the reversible
oxidative Cys modification of (a) transcription factors
(TFs) that regulate expression of proteins involved in
the autophagy process, (b) upstream regulators of
autophagy initiation, (c) autophagy proteins them-
selves and (d) receptors that mediate autophagy
substrate selectivity (Filomeni et al. 2015; Montagna
et al. 2016; Sedlackova et al. 2020).
The most substantial link between ROS and
autophagy TF activation was established in the studies
of the Mit/TFE family of transcription factors (Yang
et al. 2018). Three members of the Mit/TFE protein
family were recently shown to contain redox sensitive
Cys residues (TFEB Cys212, TFE3 Cys322, MITF
Cys281) that mediate a rapid response to increased
intracellular oxidative stress by promoting their
nuclear translocation (Wang et al. 2019a). Another
layer of regulation by oxidative stress was previously
uncovered for TFEB that regulates expression of
several autophagy proteins including, ATG4, ATG9,
LC3B and p62 (Settembre et al. 2011). Increased
intracellular oxidative stress is sensed by the lysoso-
mal cation channel, mucolipin 1 (MCOLN1/
TRPML1) in a manner that is not yet understood
(Zhang et al. 2016c). What is known is that MCOLN1
oxidation promotes channel opening, Ca2? release
from the lysosomal lumen and activation of a Ca2?
dependent phosphatase, calcineurin (Medina et al.
2015; Zhang et al. 2016c). Calcineurin-dependent
TFEB phosphorylation then promotes TFEB translo-
cation to the nucleus and autophagy stimulation
(Fig. 2A).
At the stage of autophagy execution, redox-sensi-
tive Cys residues were identified in proteins involved
in LC3 processing (ATG4B) and LC3-PE conjugation
(ATG7 and ATG3). ATG4B is a Cys-dependent
protease that cleaves pro-LC3 at a C-terminal glycine
residue prior to LC3-PE conjugation (Kirisako et al.
2000). Its protease activity is also involved in
correcting the amount of LC3–PE formation on non-
autophagic membranes by the hydrolysis of the LC3–
PE bond, and presumably on the outer membrane
leaflet of the growing autophagosome. In human cells,
the hydrolysing (deconjugating) activity of ATG4B is
inhibited by the oxidation of one of two Cys residues
(Cys74 or Cys78) and leads to improved stability of
LC3–PE and increased formation of autophagosomes
(Scherz-Shouval et al. 2007). Similarly, oxidation of
the catalytic thiols in ATG3 (Cys264) and ATG7
(Cys572) inhibits their activity in LC3–PE conjugation
and results in the loss of autophagic flux (Fig. 2b)
(Frudd et al. 2018). Interestingly, oxidation of these
Cys residues can only occur when the thiols are not
shielded by their interaction with LC3.
Oxidative stress influences the selectivity of the
autophagic process via p62, a known redox sensitive
autophagy receptor protein (Fig. 2c). Intermolecular
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disulphide formation in p62 was first observed in
studies of its involvement in the N-end rule pathway of
substrate degradation, where Cys113-dependent
oligomerisation promoted substrate clearance via
autophagy (Cha-Molstad et al. 2017). Subsequently,
we have demonstrated that elevated ROS levels
promote the formation of disulphide-linked conju-
gates, intermolecular Cys bonds, that assist p62
oligomer assembly (Carroll et al. 2018). Crucially,
we have identified two Cys residues (Cys105 and
Cys113) located within the regulatory linker region of
the p62 protein, that are necessary and sufficient for
the activation of pro-survival autophagy triggered by
increased ROS (Carroll et al. 2018).
Reversible oxidation of Cys residues in redox-
sensitive autophagy proteins thus appears to have a
dual role of pathway stimulation by autophagy gene
expression (TFEB), increased autophagosome forma-
tion (ATG4B) and substrate selectivity (p62), and
autophagy inhibition upon depletion of available LC3
substrate (ATG3, ATG7). However, due to the novelty
of these findings, the physiological role of ATG3 and
ATG7 inhibition and possible downstream signalling
events remain unknown. We propose a regulatory
feedback loop whereby sensing depletion of local LC3
pools results in inactivation of ATG3 and ATG7 that
serves to prevent indiscriminate autophagy activation.
We envision that this inactivation would persist until
such a time that the antioxidant defences decrease the
oxidative stress load and resolve the ATG3-ATG7
heterodimer, and the expression of autophagy genes
restores the available pools of ATG proteins to sustain
further autophagy.
The interrelatedness of target oxidation
and acetylation in autophagy
Protein deacetylation and oxidation appear to be
individually sufficient to regulate the initiation, pro-
motion, efficiency and selectivity of autophagy.
However, an interesting crosstalk between oxidative
and acetyl-linked PTMs of autophagy proteins arises
due to the dual control of several proteins including
TFEB, ATG3, ATG7 and p62, which appear to be
regulated by both, oxidation and acetylation status
(Fig. 2a–c). First, upstream oxidation of MCOLN1
regulates TFEB localization by calcineurin-dependent
dephosphorylation (Medina et al. 2015; Zhang et al.
2016c) and direct oxidation of its Cys212 residue
(Wang et al. 2019a). Further, TFEB deacetylation at
residues Lys274 and Lys279 promotes its dimerization
and increases its binding affinity for DNA (Wang et al.
2019b). It would be interesting to study whether
oxidation and acetylation PTMs act in concert to
establish the optimal TFEB activity and whether
TFEB oxidation promotes rapid expression of its
target genes in the absence of Lys residue
deacetylation.
Second, ATG3 acetylation at residues Lys19 and
Lys48 by TIP60, increased in conditions of nutrient
starvation, improves interaction between ATG3 and
LC3 and promotes autophagy (Yi et al. 2012). Not
much is known regarding the functional effect of
deacetylation in ATG7, except that it promotes
autophagy and Lys306 residue may be the target
(Choudhary et al. 2009). In contrast to TFEB, a
recently published study suggests that upon loss of
LC3 binding, oxidation of ATG3 (Cys264) and ATG7
(Cys572) catalytic cysteine residues inhibits their
enzymatic activity and blocks their further interaction
with LC3 (Frudd et al. 2018).
Lastly, oxidation and acetylation of p62 could act in
concert to achieve optimal selectivity of its interaction
with cargo and oligomerization to stimulate autop-
hagy. First, TIP60-dependent acetylation of Lys420
and Lys435 within the UBA domain interferes with its
inter-protein dimerization and enhances the ubiquitin
binding affinity of p62 upon serum and amino acid
starvation (You et al. 2019a). Second, oxidation of
Cys105 and Cys113 residues within the regulatory
linker region promotes intermolecular p62 disulphide
bond formation and thus assist in autophagy stimula-
tion (Carroll et al. 2018).
In addition, activity of NAD?-dependent KDACs,
or SIRTs, is directly or indirectly regulated by both,
oxidative and metabolic stress stimuli. First, a shift in
the NAD redox balance towards oxidation, suggestive
of metabolic stress, leads to an increased pool of
available NAD? and thus stimulates SIRT activity
(Imai and Guarente 2016). Second, SIRT regulation by
oxidative stress was demonstrated in multiple cell
culture experiments (reviewed in (Santos et al. 2016)),
in which a mild oxidative environment promotes
SIRT1 expression and activation by upstream kinases.
In contrast, study of SIRT1 oxidation, specifically
nitrosylation (–SNO?), suggests that this reversible
oxidative PTM of Cys371, Cys374, Cys395 and Cys398
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residues within a tetrathiolate formation results in loss
of Zn2? binding, structural destabilization and loss of
NAD? and acetyl-lysine binding ability (Kalous et al.
2016). Thus, SIRT1 activity can be stimulated by both,
nutrient starvation, and oxidative stress. However,
persistent ROS release may lead to SIRT1 destabi-
lization, loss of its deacetylase activity and might
contribute to its degradation by the proteasome (Caito
et al. 2010).
NAD depletion, oxidative stress, and autophagy
in physiological and pathological ageing
The NAD nucleotide is an important redox molecule
required for fundamental molecular processes of
energy generation via glycolysis, tricarboxylic acid
cycle, oxidative phosphorylation and b-oxidation, and
a co-factor to enzymes involved in cellular signalling
and longevity. Age-related depletion of available
NAD? pools was, in human disease, animal models
and in vitro studies, reported as a result of increased
PARP activity due to an elevation in oxidative stress
and levels of DNA damage (Pacher and Szabo 2008)
and increased CD38 expression and activity (Cama-
cho-Pereira et al. 2016; Polzonetti et al. 2012).
Combined with the age-dependent reduction in the
enzymatic activity of nicotinamide phosphoribosyl-
transferase (NAMPT), the rate-limiting enzyme of the
NAM-based NAD? salvage pathway (Stein and Imai
2014), these conditions perpetuate the perfect storm of
total NAD depletion, loss of NAM recycling and
reduction in SIRT activity in physiological ageing.
Study of human skin tissue from volunteers of
different ages partially supports these findings (Mas-
sudi et al. 2012). In this study, an age-dependent
increase in DNA damage correlated with an increase
in PARP activity, NAD? depletion and, in the elderly,
a reduction in SIRT1 activity. Notably, these associ-
ations with age were strong only in the male partic-
ipants and it would be interesting to see whether these
findings can be reproduced in females and other
accessible human tissues, including muscle or post-
mortem brain tissues. In a more recent study carried
out on human skeletal muscle samples, authors
demonstrate that levels of NAMPT negatively corre-
late with age, body mass index and body fat percent-
age (de Guia et al. 2019). Another study utilised the
power of magnetic resonance-based non-invasive
in vivo imaging of the human brain and revealed an
age-dependent decrease in total NAD levels, con-
comitant with an increase in NADH/NAD? ratio,
indicative of metabolic dysfunction (Zhu et al. 2015).
While these studies were carried out on healthy human
volunteers and suggest that a decline in NAD levels
occurs in physiological ageing, multiple studies of
accelerated human ageing (progeria) syndromes and
patients suffering from metabolic and neurodegener-
ative diseases strongly link NAD decline to age-
related pathology (Kubben and Misteli 2017; Lautrup
et al. 2019; Okabe et al. 2019).
Furthermore, studies of two age-related conditions,
sarcopenia and frailty, as well as a variety of progeria,
neurodegenerative, metabolic and cardiac diseases,
demonstrate a strong link between pathology and
increased oxidative stress (Derbre´ et al. 2014; Ingle´s
et al. 2014; Kubben and Misteli 2017; Liguori et al.
2018; Massudi et al. 2012; Soysal et al. 2017). Not
only does lipid peroxidation, a proxy measurement for
increased oxidative stress, correlate with age (Massudi
et al. 2012), a systematic review of available literature
suggests that long lived humans (centenarians) have
lower levels of oxidative protein damage and lipid
peroxidation compared to other elderly individuals
(Belenguer-Varea et al. 2019). Given the number and
severity of clinical conditions related to healthy
ageing, and age-related diseases that are associated
with an increase in oxidative stress, it is necessary to
design interventions that prevent production of free
radicals, boost cellular antioxidant systems, or under-
stand and target the processes downstream of ROS-
mediated protein, lipid or nucleotide damage.
Importantly, molecular studies of free radical
generation, NAD?-dependent enzymatic processes
and disease pathology suggest a link between ROS
accumulation, NAD depletion and compromised
mitochondrial recycling by autophagy, mitophagy.
Mitochondria are energy-generating organelles that
act as hubs of pro-survival or pro-apoptotic signalling
(Sedlackova and Korolchuk 2019). Although mito-
chondrial health is maintained by a complex net of
quality control mechanisms, whole organelle recy-
cling of damaged and ROS-producing mitochondria is
only achieved by selective autophagy. A causal link
between NAD? depletion and mitochondrial dysfunc-
tion due to loss of mitophagy was established in
studies of premature ageing syndromes including
Xeroderma Pigmentosum, Cockayne syndrome and
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Ataxia-telangiectasia (Fang et al. 2016, 2014; Schei-
bye-Knudsen et al. 2014, 2012; Valentin-Vega et al.
2012). In these studies, loss of SIRT activity and
autophagy abnormalities occur as a result of PARP1
hyperactivation due to unresolved DNA damage. In
addition to SIRT inactivation, uncontrolled NAD?
cleavage and protein PAR-ylation by PARPs results in
loss of ATP availability and, if persistent, in cell death
(Andrabi et al. 2014; Bai et al. 2011; Fouquerel et al.
2014; Pillai et al. 2005). Persistent NAD? depletion
was thus shown to compromise mitochondrial func-
tion due to loss of energy generation, impairment in
mitochondrial recycling through lack of autophagy/
mitophagy stimulation, and to initiate cellular death
due to energy collapse. An alternative outcome to cell
death upon PARP1 activation was linked to autophagy
initiation in independent cell culture experiments
(Jiang et al. 2018; Mun˜oz-Ga´mez et al. 2009). In the
earlier study, authors demonstrated that PARP-depen-
dent stimulation of autophagy due to short-lived
energy crisis had a cytoprotective effect as genetic
or pharmacological inhibition of autophagy led to
increased level of necrotic death (Mun˜oz-Ga´mez et al.
2009). In the latter study, authors aimed to mimic
constant ROS production in vivo by glucose oxidase
(GO) treatment, which led to PARP-induced cell
death, parthanatos (Jiang et al. 2018). In this study,
inhibition of autophagy led to a significant collapse in
mitochondrial polarization and an approximately 50%
increase in cell death within four hours of GO
treatment. Taken together with the role of SIRT-
mediated autophagy stimulation, we wonder whether
convergence of these signalling pathways on autop-
hagy suggests a conserved role of this catabolic
pathway in healthy ageing by preservation of cellular
NAD pools.
An exciting development in the field of ageing and
NAD metabolism is the ‘druggability’ of NAD
metabolism by exogenous addition of natural, or
synthetic, bioavailable NAD? precursors. This uni-
versal approach of NAD? precursor supplementation
is known to increase NAD biosynthesis and alleviate
the symptoms of pathological states including meta-
bolic, cardiac and neurodegenerative disorders (Kane
and Sinclair 2018; Lautrup et al. 2019). Additionally,
evidence from NAD? supplementation studies in cell
culture and in animal models suggests that boosting
NAD levels is sufficient to not only improve mito-
chondrial function, but also stimulate SIRT-dependent
mitochondrial recycling via increased TFEB- and
FoxO-dependent expression of autophagy/mitophagy
genes and PTMs of autophagy proteins, and thus
promote clearance of dysfunctional organelles and
protein aggregates (Fang et al. 2019, 2016; Hou et al.
2018; Scho¨ndorf et al. 2018; Vannini et al. 2019;
Zhang et al. 2016b). Altogether, this ‘silver bullet’
approach might serve as an intervention to the vicious
cycle of damage and NAD depletion and thus not only
combat the depletion itself, but also support resolution
of the underlying stresses and promote long-term
cellular health.
Following the success of NAD?-boosting strategies
in cell and animal models, NAD? precursors, and
predominantly nicotinamide riboside (NR), are now
subjects of multiple clinical trials. Precursors have so
far been reported as safe, well tolerated and capable of
increasing NAD levels in healthy volunteers (Conze
et al. 2019; Martens et al. 2018; Minto et al. 2017; Stea
et al. 2017). However, challenges remain in translation
of laboratory findings into the design of clinical trials
(Gilmour et al. 2020). While some early success was
found in disease outcomes of amyotrophic lateral
sclerosis (ALS) (NCT03489200) (de la Rubia et al.
2019), others found no benefit in patients with
Alzheimer’s disease (NCT00580931) (Phelan et al.
2017), or studies of metabolic disorders or mitochon-
drial bioenergetics in men (NCT02303483) (Dollerup
et al. 2018, 2019a, 2019b). Although only a limited
number of trials testing NAM, NMN and NR have
been recently completed ([ 10) or are currently
ongoing (- 3), many are actively recruiting (- 21)
(https://clinicaltrials.gov/) (Lautrup et al. 2019) and it
will be interesting to see what lessons can be learned
about precursor dosage, NAD?/NADH detection
methods and bioavailability in the coming years.
Considering that the pathological role of NAD
depletion in many metabolic and neurodegenerative
diseases is not yet firmly established, reporting of
relevant disease outcomes is eagerly awaited as they
will inform about the feasibility of translating success
from the laboratory to human age- and disease-related
interventions.
Concluding Remarks
Autophagy is a highly conserved catabolic process
that is controlled by multiple nutritional and stress-
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related cues by reversible protein PTMs. In this
review, we first explored the latest findings on how
two PTMs, Lys acetylation and Cys oxidation, regu-
late the localization and function of autophagy
proteins. Collectively, novel findings published in
2015–2020 identify TFEB, ULK1, VPS34, ATG3,
LC3 and p62 as targets of acetylation PTMs which, in
response to metabolic cues, stimulate the expression
and enzymatic activity of autophagy proteins and
improve pathway selectivity. Furthermore, Mit/TFE
family of TFs (including TFEB), ATG3, ATG7 and
p62 are also known to contain redox-sensitive Cys
residues the oxidation of which influences autophagy
outcomes. The dual control of protein localization/
enzymatic activity by acetylation and oxidation links
the efficiency of autophagy outcomes to nutrient loss
and metabolic dysfunction and thus contributes to
cellular homeostasis and healthy ageing.
Crucially, studies of the molecular mechanisms of
NAD function in cellular physiology and ageing
suggest a central role of autophagy in first, preventing
increases in DNA damage and NAD? consumption
via mitochondrial recycling and second, by alleviating
nutritional crisis via recycling amino acids, lipids and
nucleosides. Autophagy thus appears to be necessary
in supporting cellular survival upon either nutritional
stress that changes NAD redox ratio towards the
oxidised form (NAD?) and stimulates SIRTs, or upon
DNA damage followed by NAD? depletion due to
PARP1 hyperactivation. Thus, although short term
insults to cellular heath are resolved by autophagy
stimulation and cellular detoxification, we wonder
whether persistent oxidation and NAD? loss in aged
tissues result in stalled autophagy, and due to lack of
stress resolution, ultimately in loss of cell viability and
tissue dysfunction.
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